Publication | Open Access
Pyrimidinone (bropirimine) mediated alteration of T lymphocyte subsets during murine cytomegalovirus infection.
11
Citations
19
References
1987
Year
Murine CytomegalovirusImmunologyT Lymphocyte SubsetsIl-2 ReceptorsImmunologic MechanismAntiviral DrugInflammationAntiviral Drug DevelopmentMcmv Infected MiceVirologyAutoimmunityT Cell ImmunityChronic Viral InfectionMurine Cytomegalovirus InfectionAntiviral TherapyAntiviral ResponseImmunosuppressionMedicineViral Immunity
Murine cytomegalovirus (MCMV) infection of mice resulted in suppression of mitogen induced proliferation and interleukin 2 (IL-2) responses of splenic cells. This suppression was also evident as a reduction in the number of cells expressing Thy-1 or L3T4 and a reduction in the ratio of T helper/T suppressor cells. The pyrimidinone compound, bropirimine, when administered to MCMV infected mice was able to restore mitogen-induced proliferative and IL-2 responses of splenic cells, to increase the number of cells expressing Thy-1 or L3T4, to restore the ratio of T helper/T suppressor cells and to increase the number of cells inducible for expression of IL-2 receptors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1